Essilor, Sanofi Have Most Upside to PTs in Stoxx 600 Health Care
2014-01-06 15:13:08.217 GMT
By Sheela Sharma
Jan. 6 (Bloomberg) -- Essilor, Sanofi in the Stoxx 600
Health Care Index (SXDP) have scope for biggest price gains over
the next 12 months, according to Bloomberg average analyst price
targets.
* Lensmaker Essilor (EI FP) has a potential upside of ~14.5%,
followed by pharmaceuticals company Sanofi (SAN FP) at ~14%
vs an avg. 0.9% upside for all SXDP listed stocks
* Novozymes (-12%), UCB (-11%) and AstraZeneca (-10%) have
greatest scope for price declines over the next year
* NOTE: Sanofi is also one of the most highly rated SXDP
stocks among analysts, with a recommendation consensus of
4.3 and 24 of 35 analysts advising clients to buy
* Consensus score is calculated by converting each
analyst’s current recommendation into a number from 1-5
and taking the avg.
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--Editor: James Ludden
To contact the reporter on this story:
Sheela Sharma in London at +44-20-7392-0395 or
ssharma145@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
2014-01-06 15:13:08.217 GMT
By Sheela Sharma
Jan. 6 (Bloomberg) -- Essilor, Sanofi in the Stoxx 600
Health Care Index (SXDP) have scope for biggest price gains over
the next 12 months, according to Bloomberg average analyst price
targets.
* Lensmaker Essilor (EI FP) has a potential upside of ~14.5%,
followed by pharmaceuticals company Sanofi (SAN FP) at ~14%
vs an avg. 0.9% upside for all SXDP listed stocks
* Novozymes (-12%), UCB (-11%) and AstraZeneca (-10%) have
greatest scope for price declines over the next year
* NOTE: Sanofi is also one of the most highly rated SXDP
stocks among analysts, with a recommendation consensus of
4.3 and 24 of 35 analysts advising clients to buy
* Consensus score is calculated by converting each
analyst’s current recommendation into a number from 1-5
and taking the avg.
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--Editor: James Ludden
To contact the reporter on this story:
Sheela Sharma in London at +44-20-7392-0395 or
ssharma145@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net